PIK3CA and glioblastoma: Perhaps the most telling evidence for the role of the PI3K pathway in brain cancer, is that activation of PI3K pathway factors is associated with reduced survival in HGG/GBM patients [17] and the more aggressive and treatment resistant brain tumors [16].